Spanish Red Biotech Pipeline

Amgen

sotorasib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Respiratory and Pulmonary system
Indication: Untreated stage IV non-small cell lung cancer (NSCLC) with p.G12C mutation in KRAS
Phase: 2Phase II in Spain, 1Phase I in Spain